Planning Capital Management Corp Alkermes Plc. Transaction History
Planning Capital Management Corp
- $137 Billion
- Q1 2024
A detailed history of Planning Capital Management Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Planning Capital Management Corp holds 504 shares of ALKS stock, worth $12,514. This represents 0.01% of its overall portfolio holdings.
Number of Shares
504
Previous 504
-0.0%
Holding current value
$12,514
Previous $14 Million
2.41%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$724 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$501 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$370 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$224 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$207 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.08B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...